168 related articles for article (PubMed ID: 20177069)
1. Human biliverdin reductase suppresses Goodpasture antigen-binding protein (GPBP) kinase activity: the reductase regulates tumor necrosis factor-alpha-NF-kappaB-dependent GPBP expression.
Miralem T; Gibbs PE; Revert F; Saus J; Maines MD
J Biol Chem; 2010 Apr; 285(17):12551-8. PubMed ID: 20177069
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the human biliverdin reductase gene structure and regulatory elements: promoter activity is enhanced by hypoxia and suppressed by TNF-alpha-activated NF-kappaB.
Gibbs PE; Miralem T; Maines MD
FASEB J; 2010 Sep; 24(9):3239-54. PubMed ID: 20410444
[TBL] [Abstract][Full Text] [Related]
3. Biliverdin inhibits activation of NF-kappaB: reversal of inhibition by human biliverdin reductase.
Gibbs PE; Maines MD
Int J Cancer; 2007 Dec; 121(11):2567-74. PubMed ID: 17683071
[TBL] [Abstract][Full Text] [Related]
4. Formation of ternary complex of human biliverdin reductase-protein kinase Cδ-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-κB, and inducible nitric-oxidase synthase (iNOS).
Gibbs PE; Miralem T; Lerner-Marmarosh N; Tudor C; Maines MD
J Biol Chem; 2012 Jan; 287(2):1066-79. PubMed ID: 22065579
[TBL] [Abstract][Full Text] [Related]
5. The human biliverdin reductase-based peptide fragments and biliverdin regulate protein kinase Cδ activity: the peptides are inhibitors or substrate for the protein kinase C.
Miralem T; Lerner-Marmarosh N; Gibbs PE; Tudor C; Hagen FK; Maines MD
J Biol Chem; 2012 Jul; 287(29):24698-712. PubMed ID: 22584576
[TBL] [Abstract][Full Text] [Related]
6. Regulation of TNF-alpha-activated PKC-zeta signaling by the human biliverdin reductase: identification of activating and inhibitory domains of the reductase.
Lerner-Marmarosh N; Miralem T; Gibbs PE; Maines MD
FASEB J; 2007 Dec; 21(14):3949-62. PubMed ID: 17639074
[TBL] [Abstract][Full Text] [Related]
7. Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling.
Lerner-Marmarosh N; Miralem T; Gibbs PE; Maines MD
Proc Natl Acad Sci U S A; 2008 May; 105(19):6870-5. PubMed ID: 18463290
[TBL] [Abstract][Full Text] [Related]
8. Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.
Miralem T; Lerner-Marmarosh N; Gibbs PE; Jenkins JL; Heimiller C; Maines MD
FASEB J; 2016 Aug; 30(8):2926-44. PubMed ID: 27166089
[TBL] [Abstract][Full Text] [Related]
9. Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1.
Kravets A; Hu Z; Miralem T; Torno MD; Maines MD
J Biol Chem; 2004 May; 279(19):19916-23. PubMed ID: 14988408
[TBL] [Abstract][Full Text] [Related]
10. Human biliverdin reductase, a previously unknown activator of protein kinase C betaII.
Maines MD; Miralem T; Lerner-Marmarosh N; Shen J; Gibbs PE
J Biol Chem; 2007 Mar; 282(11):8110-22. PubMed ID: 17227757
[TBL] [Abstract][Full Text] [Related]
11. Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin.
Tudor C; Lerner-Marmarosh N; Engelborghs Y; Gibbs PE; Maines MD
Biochem J; 2008 Aug; 413(3):405-16. PubMed ID: 18412543
[TBL] [Abstract][Full Text] [Related]
12. Goodpasture antigen-binding protein, the kinase that phosphorylates the goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis.
Raya A; Revert-Ros F; Martinez-Martinez P; Navarro S; Rosello E; Vieites B; Granero F; Forteza J; Saus J
J Biol Chem; 2000 Dec; 275(51):40392-9. PubMed ID: 11007769
[TBL] [Abstract][Full Text] [Related]
13. A human-specific TNF-responsive promoter for Goodpasture antigen-binding protein.
Granero F; Revert F; Revert-Ros F; Lainez S; Martínez-Martínez P; Saus J
FEBS J; 2005 Oct; 272(20):5291-305. PubMed ID: 16218959
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
[TBL] [Abstract][Full Text] [Related]
15. PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit.
Jang HD; Yoon K; Shin YJ; Kim J; Lee SY
J Biol Chem; 2004 Jun; 279(23):24873-80. PubMed ID: 15140884
[TBL] [Abstract][Full Text] [Related]
16. Increased Goodpasture antigen-binding protein expression induces type IV collagen disorganization and deposit of immunoglobulin A in glomerular basement membrane.
Revert F; Merino R; Monteagudo C; Macias J; Peydró A; Alcácer J; Muniesa P; Marquina R; Blanco M; Iglesias M; Revert-Ros F; Merino J; Saus J
Am J Pathol; 2007 Nov; 171(5):1419-30. PubMed ID: 17916599
[TBL] [Abstract][Full Text] [Related]
17. p38 mitogen-activated protein kinase controls NF-kappaB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens.
Olson CM; Hedrick MN; Izadi H; Bates TC; Olivera ER; Anguita J
Infect Immun; 2007 Jan; 75(1):270-7. PubMed ID: 17074860
[TBL] [Abstract][Full Text] [Related]
18. TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway.
Jamaluddin M; Wang S; Boldogh I; Tian B; Brasier AR
Cell Signal; 2007 Jul; 19(7):1419-33. PubMed ID: 17317104
[TBL] [Abstract][Full Text] [Related]
19. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway.
Sakurai H; Suzuki S; Kawasaki N; Nakano H; Okazaki T; Chino A; Doi T; Saiki I
J Biol Chem; 2003 Sep; 278(38):36916-23. PubMed ID: 12842894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
